Abstract
At the dawn of the renaissance of bacteriophage therapy, the full acceptation of bacteriophages as anti-bacterial agents requires the determination of their basic pharmacokinetic parameters. Such data, known for all conventional drugs used in human and veterinary medicine, allow optimizing dose regimens, efficacy, and help to limit toxicity. Here, we describe basic methods to experimentally obtain pharmacokinetic data and give also examples of data calculation to determine key parameters related to the biodistribution and elimination of bacteriophages in vivo.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Ding H, Wu F (2012) Image guided biodistribution and pharmacokinetic studies of theranostics. Theranostics 2(11):1040–1053. https://doi.org/10.7150/thno.4652
Isin EM, Elmore CS, Nilsson GN, Thompson RA, Weidolf L (2012) Use of radiolabeled compounds in drug metabolism and pharmacokinetic studies. Chem Res Toxicol 25(3):532–542. https://doi.org/10.1021/tx2005212
Matthews PM, Rabiner EA, Passchier J, Gunn RN (2012) Positron emission tomography molecular imaging for drug development. Br J Clin Pharmacol 73(2):175–186. https://doi.org/10.1111/j.1365-2125.2011.04085.x
Perkins AC, Pimm MV, Wilson CG (1994) Gamma scintigraphy in the delivery, biodistribution and targeting of therapeutic agents. J Nucl Biol Med 38(4 Suppl 1):113–118
Vasquez KO, Casavant C, Peterson JD (2011) Quantitative whole body biodistribution of fluorescent-labeled agents by non-invasive tomographic imaging. PLoS One 6(6):e20594. https://doi.org/10.1371/journal.pone.0020594
Palm S, Enmon RM Jr, Matei C, Kolbert KS, Xu S, Zanzonico PB, Finn RL, Koutcher JA, Larson SM, Sgouros G (2003) Pharmacokinetics and Biodistribution of (86)Y-Trastuzumab for (90)Y dosimetry in an ovarian carcinoma model: correlative MicroPET and MRI. J Nucl Med 44(7):1148–1155
Geier MR, Trigg ME, Merril CR (1973) Fate of bacteriophage lambda in non-immune germ-free mice. Nature 246(5430):221–223
Inchley CJ (1969) The actvity of mouse Kupffer cells following intravenous injection of T4 bacteriophage. Clin Exp Immunol 5(1):173–187
Nungester WJ, Watrous RM (1934) Accumulation of bacteriophage in spleen and liver following its intravenous inoculation. Proc Soc Exp Biol Med 31:901–905
Yip YL, Hawkins NJ, Smith G, Ward RL (1999) Biodistribution of filamentous phage-Fab in nude mice. J Immunol Methods 225(1-2):171–178
Zou J, Dickerson MT, Owen NK, Landon LA, Deutscher SL (2004) Biodistribution of filamentous phage peptide libraries in mice. Mol Biol Rep 31(2):121–129
Singla S, Harjai K, Raza K, Wadhwa S, Katare OP, Chhibber S (2016) Phospholipid vesicles encapsulated bacteriophage: a novel approach to enhance phage biodistribution. J Virol Methods 236:68–76. https://doi.org/10.1016/j.jviromet.2016.07.002
Farkas ME, Aanei IL, Behrens CR, Tong GJ, Murphy ST, O'Neil JP, Francis MB (2013) PET Imaging and biodistribution of chemically modified bacteriophage MS2. Mol Pharm 10(1):69–76. https://doi.org/10.1021/mp3003754
De Paepe M, Tournier L, Moncaut E, Son O, Langella P, Petit MA (2016) Carriage of lambda latent virus is costly for its bacterial host due to frequent reactivation in monoxenic mouse intestine. PLoS Genet 12(2):e1005861. https://doi.org/10.1371/journal.pgen.1005861
Abedon ST, Thomas-Abedon C (2010) Phage therapy pharmacology. Curr Pharm Biotechnol 11(1):28–47
Turner PV, Brabb T, Pekow C, Vasbinder MA (2011) Administration of substances to laboratory animals: routes of administration and factors to consider. J Am Assoc Lab Anim Sci 50(5):600–613
National Centre for the Replacement Refinement and Reduction of Animals in Research (2016) Techniques for taking blood samples from laboratory mice.. https://www.nc3rs.org.uk/mouse. Accessed August 2016
Kaliss N, Pressman D (1950) Plasma and blood volumes of mouse organs, as determined with radioactive iodoproteins. Proc Soc Exp Biol Med 75(1):16–20
Linderkamp O, Berg D, Betke K, Koferl F, Kriegel H, Riegel KP (1980) Blood volume and hematocrit in various organs in newborn piglets. Pediatr Res 14(12):1324–1327. https://doi.org/10.1203/00006450-198012000-00010
Maura D, Galtier M, Le Bouguenec C, Debarbieux L (2012) Virulent bacteriophages can target O104:H4 enteroaggregative Escherichia coli in the mouse intestine. Antimicrob Agents Chemother 56(12):6235–6242. https://doi.org/10.1128/AAC.00602-12
Debarbieux L, Leduc D, Maura D, Morello E, Criscuolo A, Grossi O, Balloy V, Touqui L (2010) Bacteriophages can treat and prevent Pseudomonas aeruginosa lung infections. J Infect Dis 201(7):1096–1104. https://doi.org/10.1086/651135
Dhillon S, Gill K (2006) Basic pharmacokinetics. Clinical Pharmacokinetics. Pharmaceutical Press, London
Boulanger P (2009) Purification of bacteriophages and SDS-PAGE analysis of phage structural proteins from ghost particles. Methods Mol Biol 502:227–238. https://doi.org/10.1007/978-1-60327-565-1_13
Boratynski J, Syper D, Weber-Dabrowska B, Lusiak-Szelachowska M, Pozniak G, Gorski A (2004) Preparation of endotoxin-free bacteriophages. Cell Mol Biol Lett 9(2):253–259
Burden D (2012) Guide to the disruption of biological samples. Random Primers 12:1–25
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer Science+Business Media LLC
About this protocol
Cite this protocol
Dufour, N., Delattre, R., Debarbieux, L. (2018). In Vivo Bacteriophage Biodistribution. In: Azeredo, J., Sillankorva, S. (eds) Bacteriophage Therapy. Methods in Molecular Biology, vol 1693. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-7395-8_11
Download citation
DOI: https://doi.org/10.1007/978-1-4939-7395-8_11
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-7394-1
Online ISBN: 978-1-4939-7395-8
eBook Packages: Springer Protocols